Great Point Partners LLC Decreases Position in Context Therapeutics Inc. to 2.44%

2026-05-15SEC Filing SCHEDULE 13G/A (0001172661-26-002036)

Great Point Partners, LLC, along with Dr. Jeffrey R. Jay and Ms. Lillian Nordahl, filed a Schedule 13G/A on May 15, 2026, regarding their holdings in Context Therapeutics Inc. (CNTX). The filing indicates that the reporting persons collectively hold 2,238,496 shares of common stock, representing a 2.44% ownership stake in the company. This represents a significant decrease in ownership percentage from previous filings, as the group now holds less than the 5% threshold typically requiring active monitoring. The shares are held with shared voting and dispositive power among the reporting persons. The filing confirms that the securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The calculation of the ownership percentage is based on 91,879,177 shares outstanding as of the issuer's most recent annual report. The principal business office for the reporting persons is located in Greenwich, Connecticut.

Ticker mentioned:CNTXInstitution mentioned:GREAT POINT PARTNERS LLC
Related industry:Biotechnology